Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
UBE2L6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ARHGAP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TXNL4B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
COMMD7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLFN12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MRPS9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CD2BP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRAF6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FRMD8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM54 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIR7113 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NAT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
POLR3K - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM219 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GINS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DDAH2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RDX - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EXO5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on